FDA Grants Regular Approval to Duvelisib
Citations
American Society of Hematology. (1).
FDA Grants Regular Approval to Duvelisib.
Retrieved from https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-grants-regular-approval-to-duvelisib.
American Society of Hematology.
"FDA Grants Regular Approval to Duvelisib." Hematology.org.
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-grants-regular-approval-to-duvelisib
(label-accessed July 27, 2024).
"American Society of Hematology."
FDA Grants Regular Approval to Duvelisib, 27 Jul. 2024 ,
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-grants-regular-approval-to-duvelisib.
Related Content
![ASH Logo](/-/media/system/default-images/ash_dei_logo.png?la=en&h=183&w=183&hash=4680D6D95E3103051693E4B181F4A617)
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
![People smile within a treatment of the ASH Logo.](/-/media/system/default-images/ash_dei_desktop.png?la=en&h=563&w=398&hash=4831E7489142716EF885D6F7E6CAF630)
![People smile within a treatment of the ASH Logo.](/-/media/system/default-images/ash_dei_mobile.png?la=en&h=368&w=356&hash=4F024197AE234DA190732D54E084BCA4)
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission